The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
REGULATION OF MHC CLASS II GENES: Lessons from a Disease
Open accessAbstract
▪ Abstract Precise regulation of major histocompatibility complex class II (MHC-II) gene expression plays a crucial role in the control of the immune response. A major breakthrough in the elucidation of the molecular mechanisms involved in MHC-II regulation has recently come from the study of patients that suffer from a primary immunodeficiency resulting from regulatory defects in MHC-II expression. A genetic complementation cloning approach has led to the isolation of CIITA and RFX5, two essential MHC-II gene transactivators. CIITA and RFX5 are mutated in these patients, and the wild-type genes are capable of correcting their defect in MHC-II expression. The identification of these regulatory factors has furthered our understanding of the molecular mechanisms that regulate MHC-II genes. CIITA was found to be a non-DNA binding transactivator that functions as a molecular switch controlling both constitutive and inducible MHC-II expression. The finding that RFX5 is a subunit of the nuclear RFX-complex has confirmed that a deficiency in the binding of this complex is indeed the molecular basis for MHC-II deficiency in the majority of patients. Furthermore, the study of RFX has demonstrated that MHC-II promoter activity is dependent on the binding of higher-order complexes that are formed by highly specific cooperative binding interactions between certain MHC-II promoter-binding proteins. Two of these proteins belong to families of which the other members, although capable of binding to the same DNA motifs, are probably not directly involved in the control of MHC-II expression. Finally, the facts that CIITA and RFX5 are both essential and highly specific for MHC-II genes make possible novel strategies designed to achieve immunomodulation via transcriptional intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B. (1994) · Science · doi:10.1126/science.8016643 · Cited by 898
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
Self-citationSuperantigens: Mechanism Of T Cell Stimulation And Role In Immune-Responses
Herman, A. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.745 · Cited by 794
Role of MHC Gene Products in Immune Regulation
Benacerraf, B. (1981) · Science · doi:10.1126/science.6165083 · Cited by 696
HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading
Denzin, L. K., & Cresswell, P. (1995) · Cell · doi:10.1016/0092-8674(95)90061-6 · Cited by 686
Essential role for ZAP-70 in both positive and negative selection of thymocytes
Negishi, I., Motoyama, N., Nakayama, K.-I., Nakayama, K., Senju, S., Hatakeyama, S., Zhang, Q., Chan, A. C., & Loh, D. Y. (1995) · Nature · doi:10.1038/376435a0 · Cited by 554
Mediation by HLA-DM of dissociation of peptides from HLA-DR
Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., & Zaller, D. M. (1995) · Nature · doi:10.1038/375802a0 · Cited by 546
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Rock, C. S., & Lowry, S. F. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90146-d · Cited by 503
Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Wolffe, A. P. (1994) · BioEssays · doi:10.1002/bies.950160407 · Cited by 381
Steimle, V, Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., & Reith, W. (1995) · Genes & Development · doi:10.1101/gad.9.9.1021 · Cited by 338
Self-citationChang, C. H., Fontes, J. D., Peterlin, M., & Flavell, R. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1367 · Cited by 329
Involvement of the IRF-1 Transcription Factor in Antiviral Responses to Interferons
Kimura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilček, J., Mak, T. W., et al. (1994) · Science · doi:10.1126/science.8009222 · Cited by 304
Sinha, S., Maity, S. N., Lu, J., & de Crombrugghe, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1624 · Cited by 295
Interleukin 13 is a B cell stimulating factor.
Defrance, T., Carayon, P., Billian, G., Guillemot, J. C., Minty, A., Caput, D., & Ferrara, P. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.135 · Cited by 294
A New Member of the Leucine Zipper Class of Proteins that Binds to the HLA DRα Promoter
Liou, H.-C., Boothby, M. R., Finn, P. W., Davidon, R., Nabavi, N., Zeleznik-Le, N. J., Ting, J. P.-Y., & Glimcher, L. H. (1990) · Science · doi:10.1126/science.2321018 · Cited by 290
Organ‐Specific Autoimmunity: A 1986 Overview
Bottazzo, G. F., Todd, I., Mirakian, R., Belfiore, A., & Pujol‐Borrell, R. (1986) · Immunological Reviews · doi:10.1111/j.1600-065x.1986.tb01168.x · Cited by 267
Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
Chang, C. H., & Flavell, R. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.765 · Cited by 267
Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits.
Hooft van Huijsduijnen, R., Li, X. Y., Black, D., Matthes, H., Benoist, C., & Mathis, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07509.x · Cited by 258
A new human HLA class II-related locus, DM
Kelly, A. P., Monaco, J. J., Cho, S., & Trowsdale, J. (1991) · Nature · doi:10.1038/353571a0 · Cited by 255
Reith, W., Satola, S., Sanchez, C. H., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M. R., & Mach, B. (1988) · Cell · doi:10.1016/s0092-8674(88)90389-3 · Cited by 255
Self-citationDominant negative analogs of NF-YA.
Mantovani, R., Li, X. Y., Pessara, U., Hooft van Huisjduijnen, R., Benoist, C., & Mathis, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31997-x · Cited by 231
Ivashkiv, L. B., Liou, H. C., Kara, C. J., Lamph, W. W., Verma, I. M., & Glimcher, L. H. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1609 · Cited by 229
T cell recognition as the target for immune intervention in autoimmune disease
Wraith, D. C., McDevitt, H. O., Steinman, L., & Acha-Orbea, H. (1989) · Cell · doi:10.1016/0092-8674(89)90786-1 · Cited by 214
Regulation of MHC gene expression
Ting, J. P.-Y., & Baldwin, A. S. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90074-3 · Cited by 212
Dorn, A., Durand, B., Marfing, C., Le Meur, M., Benoist, C., & Mathis, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6249 · Cited by 204
Suzuki, H., Punt, J. A., Granger, L. G., & Singer, A. (1995) · Immunity · doi:10.1016/1074-7613(95)90149-3 · Cited by 204
Superantigens of Mouse Mammary Tumor Virus
Acha-Orbea, H., & MacDonald, H. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002331 · Cited by 193
Compartmentalization of MHC class II gene expression in transgenic mice
van Ewijk, W., Ron, Y., Monaco, J., Kappler, J., Marrack, P., Le Meur, M., Gerlinger, P., Durand, B., Benoist, C., & Mathis, D. (1988) · Cell · doi:10.1016/0092-8674(88)90156-0 · Cited by 191
Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription.
Mantovani, R., Pessara, U., Tronche, F., Li, X. Y., Knapp, A. M., Pasquali, J. L., Benoist, C., & Mathis, D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05410.x · Cited by 189
Genomic structure and function in the MHC
Trowsdale, J. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90205-v · Cited by 188
Riley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A., & Boss, J. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90033-0 · Cited by 177
Reith, W., Siegrist, C. A., Durand, B., Barras, E., & Mach, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.554 · Cited by 176
Self-citationIn vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome
Kara, C., & Glimcher, L. (1991) · Science · doi:10.1126/science.1902592 · Cited by 167
Chin, K., Mao, C., Skinner, C., Riley, J. L., Wright, K., Moreno, C. S., Stark, G. R., Boss, J. M., & Tingt, J. P. Y. (1994) · Immunity · doi:10.1016/1074-7613(94)90039-6 · Cited by 165
Reith, W., Herrero-Sanchez, C., Kobr, M., Silacci, P., Berte, C., Barras, E., Fey, S., & Mach, B. (1990) · Genes & Development · doi:10.1101/gad.4.9.1528 · Cited by 164
Self-citationSilacci, P., Mühlethaler‐Mottet, A., Steimle, V., Reith, W., & Mach, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1329 · Cited by 158
Self-citationZhou, H., & Glimcher, L. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90034-9 · Cited by 154
Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells
Karlsson, L., Péleraux, A., Lindstedt, R., Liljedahl, M., & Peterson, P. A. (1994) · Science · doi:10.1126/science.7985028 · Cited by 144
Wright, K. L., Vilen, B. J., Itoh-Lindstrom, Y., Moore, T. L., Li, G., Criscitiello, M. F., Cogswell, P. C., Clarke, J. B., & Ting, J. P. ‐. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06721.x · Cited by 139
Reith, W., Ucla, C., Barras, E., Gaud, A., Durand, B., Sanchez, C. H., Kobr, M., & Mach, B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1230 · Cited by 139
Self-citationCombined immunodeficiency with defective expression in MHC class II genes.
Griscelli, C., Lisowska‐Grospierre, B., & Mach, B. (1989) · PubMed · Cited by 134
Self-citationTumor immunotherapy: the tumor cell as an antigen-presenting cell
Ostrand‐Rosenberg, S. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90075-2 · Cited by 130
Ono, S. J., Liou, H., Davidon, R., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4309 · Cited by 126
Bénichou, B., & Strominger, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4285 · Cited by 120
Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors.
Tsang, S. Y., Nakanishi, M., & Peterlin, B. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.711 · Cited by 114
Loughlin, J., Woodroofe, M. N., & Cuzner, M. L. (1993) · PubMed · Cited by 109
Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases.
Guardiola, J., & Maffei, A. (1993) · PubMed · Cited by 109
The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes
Kern, I., Steimle, V., Siegrist, C., & Mach, B. (1995) · International Immunology · doi:10.1093/intimm/7.8.1295 · Cited by 107
Self-citationPanek, R. B., & Benveniste, E. N. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2846 · Cited by 107
Immune Responses in MHC Class II-Deficient MICE
Grusby, M. J., & Glimcher, L. H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002221 · Cited by 105
Klein, C., Cavazzana, M., Deist, F. L., Jabado, N., Benkerrou, M., Blanche, S., Lisowska‐Grospierre, B., Griscelli, C., & Fischer, A. (1995) · Blood · doi:10.1182/blood.v85.2.580.580 · Cited by 104
Paglia, P., Girolomoni, G., Robbiati, F., Granucci, F., & Ricciardi‐Castagnoli, P. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.1893 · Cited by 104
Zebrafish Mhc class II ? chain-encoding genes: polymorphism, expression, and function
S�ltmann, H., Mayer, W., Figueroa, F., Ó’hUigín, C., & Klein, J. (1993) · Immunogenetics · doi:10.1007/bf00184521 · Cited by 103
Kara, C. J., Liou, H., Ivashkiv, L. B., & Glimcher, L. H. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1347 · Cited by 102
MHC class II signaling in B-cell activation
Scholl, P. R., & Geha, R. S. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90271-2 · Cited by 96
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.
Reith, W., Kobr, M., Emery, P., Durand, B., Siegrist, C., & Mach, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32121-x · Cited by 94
Self-citationSiegrist, C., Durand, B., Emery, P., David, E., Hearing, P., Mach, B., & Reith, W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6375 · Cited by 79
Self-citationZeleznik‐Le, N. J., Azizkhan, J. C., & Ting, J. P. ‐. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1873 · Cited by 74
CIITA activates the expression of MHC class II genes in mouse T cells
Chang, C., Hong, S., Hughes, C. C. W., Janeway, C. A., & Flavell, R. A. (1995) · International Immunology · doi:10.1093/intimm/7.9.1515 · Cited by 74
Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes
Reith, W., Steimle, V., & Mach, B. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80048-4 · Cited by 72
Self-citationSong, Z., Krishna, S., Thanos, D., Strominger, J. L., & Ono, S. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1763 · Cited by 72
Kobr, M., Reith, W., Sanchez, C. H., & Mach, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.965 · Cited by 69
Self-citationHasegawa, S. L., & Boss, J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.22.6269 · Cited by 66
Wright, K. L., & Ting, J. P. ‐. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7601 · Cited by 66
Carson, S., & Wiles, M. V. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.9.2065 · Cited by 61
Abdulkadir, S. A., Krishna, S., Thanos, D., Maniatis, T., Strominger, J. L., & Ono, S. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.487 · Cited by 61
Loh, J. E., Chang, C., Fodor, W. L., & Flavell, R. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05180.x · Cited by 57
Two complementation groups account for most cases of inherited MHC class II deficiency
Lisowska‐Grospierre, B., Fondanèche, M., Rols, M., Griscelli, C., & Fischer, A. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.6.953 · Cited by 57
Latron, F., Jotterand-Bellomo, M., Maffei, A., Scarpellino, L., Bernard, M., Strominger, J. L., & Accolla, R. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2229 · Cited by 57
NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun.
Andersson, G. N., & Peterlin, B. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3456 · Cited by 53
Sloan, J. H., Hasegawa, S. L., & Boss, J. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2591 · Cited by 51
Zhang, X. Y., Jabrane‐Ferrat, N., Asiedu, C. K., Samac, S., Peterlin, B. M., & Ehrlich, M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6810 · Cited by 48
Hauber, I., Gulle, H., Wolf, H. M., Maris, M., Eggenbauer, H., & Eibl, M. M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1411 · Cited by 48
Ono, S. J., Bažil, V., Levi, B.-Z., Ozato, K., & Strominger, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4304 · Cited by 47
The E alpha promoter: a linker-scanning analysis
Viville, S., Jongeneel, C. V., Koch, W., Mantovani, R., Benoist, C. O., & Mathis, D. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3211 · Cited by 45
Gönczy, P., Reith, W., Barras, E., Lisowska‐Grospierre, B., Griscelli, C., Hadam, M. R., & Mach, B. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.1.296 · Cited by 41
Self-citationThe Immune System of Mice Lacking Conventional MHC Class II Molecules
Cardell, S., Merkenschlager, M., Bodmer, H. C., Chan, S. H., Cosgrove, D. E., Benoist, C. O., & Mathis, D. J. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60515-5 · Cited by 40
Brown, A., Wright, K. L., & Ting, J. P. ‐. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74318-x · Cited by 40
Moses, H. L., Panek, R. B., Benveniste, E. N., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3643 · Cited by 38
Stimulation of B lymphocytes via CD72 (human Lyb‐2)
Kamal, M., Katira, A., & Gordon, J. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210614 · Cited by 36
Siegrist, C., Martínez-Soria, E., Kern, I., & Mach, B. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1793 · Cited by 35
Self-citationMao, C. D., Davies, D. C., Kerr, I. M., & Stark, G. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2880 · Cited by 33
Definition of a novel complementation group in MHC class II deficiency
Peijnenburg, A., Godthelp, B. C., van Boxel-Dezaire, A. H. H., & van den Elsen, P. J. (1995) · Immunogenetics · doi:10.1007/bf00172153 · Cited by 31
Panek, R. B., Lee, Y. J., Itoh-Lindstrom, Y., Ting, J. P. ‐., & Benveniste, E. N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4555 · Cited by 30
B-Cell Factor 1 Is Required for Optimal Expression of the DRA Promoter in B Cells
Voliva, C. F., Aronheim, A., WALKER, M. D., & Peterlin, B. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2383 · Cited by 22
Siegrist, C., & Mach, B. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231126 · Cited by 20
Self-citationSugawara, M., Scholl, T., Ponath, P. D., & Strominger, J. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8438 · Cited by 20
Ets-1 Activates the DRA Promoter in B Cells
Jabrane‐Ferrat, N., & Peterlin, B. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7314 · Cited by 19
Acha‐Orbea, H., & McDevitt, H. O. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75239-1_8 · Cited by 18
Steimle, V., & Mach, B. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80034-4 · Cited by 16
Self-citationFine-tuning of MHC class II gene expression in defined microenvironments
Fehling, H. J., Viville, S., van Ewijk, W., Benoist, C. O., & Mathis, D. J. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90140-6 · Cited by 14
Itoh-Lindstrom, Y., Peterlin, B. M., & Ting, J. P. ‐. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.282 · Cited by 10
Sugawara, M., Scholl, T., Mahanta, S. K., Ponath, P. D., & Strominger, J. L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.175 · Cited by 7
Regulation of Transgenic Class II Major Histocompatibility Genes in Murine Langerhans Cells
Longley, J. B., Ding, T.-G., Levin, D., Lewis, J. M., Edelson, R. L., Tigelaar, R. E., & Flavell, R. A. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12665365 · Cited by 4
Cited by
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Dong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
Metadata
- Authors
- Mach, B., Steimle, V., Martinez-Soria, E., & Reith, W.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1996-04
- Volume
- 14
- Issue
- 1
- Pages
- 301-331
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2112093664
- Cited by
- 486
- References
- 99
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.